News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Many Non-Antibiotic Drugs Affect Gut Bacteria
Catherine Offord | Mar 20, 2018
A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.
Flu Drug Approved in Japan Claims to Stop Virus in 24 Hours
Kerry Grens | Feb 26, 2018
One dose of the medication, called Xofluza, cripples influenza by interfering with an enzyme critical for viral replication.
Antiviral Immunotherapy Comes of Age
Lucas Laursen | Dec 4, 2017
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections.
Scientists Look to Epigenetics to Thwart Viruses
Shawna Williams | Sep 1, 2017
Some viral pathogens modify chromatin and other epigenetic machinery, making them appealing drug targets.
Child Lives with HIV for Years Without Treatments
Bob Grant | Jul 24, 2017
Another case of HIV remission emerges, this time in a South African girl diagnosed as an infant and disease-free for more than eight years.
Cross-Reactive Ebola Antibodies
Anna Azvolinsky | Jan 21, 2016
Human monoclonal antibodies induced during Ebola infection are able to neutralize related viral species, scientists show.
RNA Ebola Drug Clears Animal Study
Jef Akst | Apr 24, 2015
The short interfering RNA-based therapy TKM-Ebola protects monkeys from the viral strain still circulating in West Africa.
Ebola Drug Trials to Start in Africa
Bob Grant | Nov 13, 2014
Researchers will test antiviral drugs and transfusions of blood from Ebola survivors in the West African countries hardest hit by the epidemic.
Disease Returns to Second Child “Cured” of HIV
Bob Grant | Oct 5, 2014
Like the Mississippi child that was thought to have beaten HIV after aggressive anti-retroviral treatment, detectable levels of the virus return in an Italian child who received similar therapy.
Speeding Up Antiviral T Cell Production
Ruth Williams | Jun 25, 2014
Scientists come up with a simpler, more efficient strategy for making multivirus-targeting T cells for immunotherapy.